Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Argus Health
Chinese Patent Office
Julphar
Accenture
Colorcon
Deloitte
Federal Trade Commission

Generated: December 16, 2018

DrugPatentWatch Database Preview

Drug Price Trends for POTASSIUM CL ER

« Back to Dashboard

Drug Price Trends for POTASSIUM CL ER

Average Pharmacy Cost for POTASSIUM CL ER

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
POTASSIUM CL ER 10 MEQ TABLET 64380-0861-08 0.16014 EA 2018-12-05
POTASSIUM CL ER 10 MEQ TABLET 64380-0861-07 0.16014 EA 2018-12-05
POTASSIUM CL ER 10 MEQ TABLET 64380-0861-06 0.16014 EA 2018-12-05
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Cerilliant
US Army
McKinsey
Colorcon
QuintilesIMS
Covington
Queensland Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.